Literature DB >> 8724957

Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma.

J W Harbour1, T G Murray, S F Byrne, J R Hughes, E K Gendron, F J Ehlies, A M Markoe.   

Abstract

PURPOSE: Plaque radiotherapy has been reported to have a higher relapse rate than charged-particle radiotherapy for posteriorly located uveal melanomas, which also are more technically difficult to localize accurately. The authors used intraoperative echography in patients with posterior uveal melanoma to determine the rate of inaccurate localization of iodine 125(125I) episcleral plaques using standard localization techniques.
METHODS: The authors reviewed the records of 29 consecutive patients with medium-sized posterior uveal melanomas who underwent 125I episcleral plaque radiotherapy with intraoperative echographic verification of plaque placement.
RESULTS: After careful plaque placement using standard localization techniques, 4 of 29 plaques (14%) did not cover at least one tumor margin. All four of these plaques were associated with posterior tumors with at least one margin posterior to the temporal arcades. Two (7%) additional juxtapapillary plaques were displaced away from the sclera by the optic nerve. In all six cases, it was possible to immediately reposition the plaque to achieve coverage of all tumor margins.
CONCLUSIONS: Placement of 125I episcleral radioactive plaques for posteriorly located uveal melanomas using standard localization techniques occasionally results in suboptimal plaque positioning. Intraoperative echography can identify plaques that are localized poorly and allows immediate adjustment to achieve optimal plaque positioning.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8724957     DOI: 10.1097/00006982-199616020-00008

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  21 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Finger's "slotted" eye plaque for radiation therapy: treatment of juxtapapillary and circumpapillary intraocular tumours.

Authors:  Paul T Finger
Journal:  Br J Ophthalmol       Date:  2007-02-27       Impact factor: 4.638

3.  A biological tissue adhesive and dissolvent system for intraocular tumor plaque radiotherapy: an in vivo animal model experiment.

Authors:  Ofira Zloto; Dror Alezra; Oded Sagiv; Michael Belkin; Vicktoria Vishnevskia Dai; Iris Moroz; Gahl Greenberg; Elad Ben-Artsi; Ido Didi Fabian
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-27       Impact factor: 3.117

4.  Dose Distributions and Treatment Margins in Ocular Brachytherapy with 106Ru Eye Plaques.

Authors:  Erik Stöckel; Marion Eichmann; Dirk Flühs; Holger Sommer; Eva Biewald; Norbert Bornfeld; Bernhard Spaan; Wolfgang Sauerwein
Journal:  Ocul Oncol Pathol       Date:  2017-09-16

Review 5.  Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Authors:  Patrick Oellers; Prithvi Mruthyunjaya
Journal:  Melanoma Manag       Date:  2016-02-17

6.  A Modified Dummy Plaque for the Accurate Placement of Ruthenium-106 Plaques in Brachytherapy of Intraocular Tumours.

Authors:  Jørgen Krohn
Journal:  Ocul Oncol Pathol       Date:  2015-06-05

7.  Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma.

Authors:  Andrea Russo; Michela Laguardia; Bertil Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-23       Impact factor: 3.117

Review 8.  Iodine-125 Brachytherapy for Uveal Melanoma: A Systematic Review of Radiation Dose.

Authors:  Jose J Echegaray; Nikolaos E Bechrakis; Nakul Singh; Claudine Bellerive; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2017-02-08

9.  Clinical evaluation of a paper chart for predicting ruthenium plaque placement in relation to choroidal melanoma.

Authors:  I Rospond-Kubiak; J Kociecki; B Damato
Journal:  Eye (Lond)       Date:  2017-09-29       Impact factor: 3.775

10.  Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity.

Authors:  Nisha V Shah; Samuel K Houston; Arnold M Markoe; William Feuer; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2012-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.